Hesai (HSAI) analyst forecast and price target
Analyst forecast
Consensus of 25 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Amerx | Maintained | Hold | — | Aug 20, 2026 |
| Amerx | Maintained | Hold | — | May 20, 2026 |
| Amerx | Initiated Coverage | Hold | — | May 11, 2026 |
| CICC | Initiated Coverage | Outperform | $23.50 | Nov 25, 2025 |
| Goldman Sachs | Maintained | Buy | $36.00 from $26.30 | Sep 22, 2025 |
| UBS | Initiated Coverage | Buy | $35.00 | Aug 19, 2025 |
| Morgan Stanley | Upgraded | Equal-Weight → Overweight | $26.00 from $23.00 | Jul 28, 2025 |
| Jefferies | Initiated Coverage | Buy | $29.30 | Jun 9, 2025 |
| Citigroup | Initiated Coverage | Buy | $12.90 | Sep 26, 2023 |
| Goldman Sachs | Downgraded | Buy → Neutral | — | Aug 18, 2023 |
Frequently asked questions
Is HSAI a buy, sell, or hold?
Analysts covering Hesai currently average a Buy rating: 24 buy, 1 hold and 0 sell, from 25 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on HSAI?
On Aug 20, 2026, Amerx maintained Hesai at Hold.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.